Complete Revascularization in Patients With STEMI and Multi-Vessel Disease: A Meta-Analysis of Randomized Controlled Trials
Highlights
- • Patients with acute coronary syndrome usually have multi-vessel disease.
- • Revascularization of the Culprit lesion is paramount, while revascularization of the non-culprit lesions is still debatable.
- • Complete revascularization was associated with decrease in MACE, cardiovascular mortality and repeat revascularization.
Abstract
Background
Percutaneous coronary intervention (PCI) is the treatment of choice for ST-elevation myocardial infarction (STEMI). However, efficacy of complete vs culprit only revascularization in patients with STEMI and multivessel disease remains unclear.